Skip to main content
Scienza Health
PAC/LTC Operations

HIPAA-Compliant Voice AI in Post-Acute Care

David Kaiser, Founder & CEO··Updated April 12, 2026·3 min read
Share

Ensuring HIPAA compliance is non-negotiable when implementing AI in [post-acute care](/screening). [digitalhumanOS™](/platform) prioritizes data privacy and security.

Last updated: April 2026Reviewed quarterly

Key Facts

  • HIPAA compliance is paramount when using AI in post-acute care.
  • digitalhumanOS™ ensures data privacy and security.
  • Protecting patient information is a top priority.

Ensuring HIPAA compliance is non-negotiable when implementing AI in post-acute care. digitalhumanOS™ prioritizes data privacy and security. It implements robust safeguards to protect patient information and maintain compliance with all relevant regulations. This ensures that facilities can leverage the power of AI without compromising patient privacy.

Data Privacy

Prioritize data privacy with robust security measures and protocols.

Security Measures

Implement stringent security measures to protect patient information.

FREE GUIDE

The Operator's Guide to Multimodal Clinical AI

What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.

Compliance

Maintain compliance with all relevant HIPAA regulations and guidelines.

Patient Trust

Build trust with patients by ensuring the privacy of their data.

Conclusion

digitalhumanOS™ ensures HIPAA compliance. Leverage AI with confidence, knowing that patient privacy is protected. Prioritize security and compliance. Learn how digitalhumanOS™ meets HIPAA, SOC 2, and 510(k) requirements.

Sources & References

  1. Scienza Health: FDA 510(k) cleared. Class II Exempt. Registered as Computerized Cognitive Assessment Aid.
  2. Translating AI Research into Reality: Summary of the 2025 Voice AI Symposium. Frontiers in Digital Health. DOI: 10.3389/fdgth.2026.1754426.
  3. Scienza Health internal validation: 12.3M patients, 27B clinical events, dual Large Acoustic Model architecture.
DK
David KaiserFounder & CEO

David Kaiser is the Founder and CEO of Scienza Health. He leads the development of GIA® and digitalhumanOS™, a clinically validated speech biomarker platform that screens for 46 cognitive and neurological conditions in under 5 minutes.

510(k) ClearedEditorially reviewed·

This content is intended for informational purposes and does not constitute medical advice. Editorially reviewed by David Kaiser, CEO of Scienza Health, for accuracy in post-acute care operations.

Frequently Asked Questions

Is digitalhumanOS™ HIPAA compliant?

Yes, it is designed with HIPAA compliance in mind.

What security measures are in place?

Encryption, access controls, and regular audits.

How is data protected?

Through a multi-layered security approach.

Share
PODCASTPrefer to listen?

The Clinical Signal

Hear the latest episode on clinical AI screening in post-acute care.

Schedule a Demo

See what 40 seconds of speech reveals.

See What You're Missing